Loading
Machine Learning in Bioinformatics / Ai in Cancer Detection / Cancer Cells and Metastasis · Journal article
Wartificial Intelligence in Cancer · August 14, 2026
Raises a question worth testing. It does not answer one.
This is a narrative mini-review synthesizing published literature on the potential role of AI and machine learning in understanding cancer cell plasticity and treatment response prediction. It presents conceptual applications and future research directions rather than original empirical evidence or clinical trial results.
Narrative mini-review.
AI-driven deep learning and machine learning integrated with next-generation sequencing may elucidate changes in tumor plasticity trajectories AI applications proposed for molecular landscape deciphering in normal, metaplastic, and pre-malignant tissues AI cited as playing roles in drug discovery, pharmacokinetic analysis, and drug repurposing
AI cited as playing roles in drug discovery, pharmacokinetic analysis, and drug repurposing
The source did not state who this applies to in practice.
A narrative mini-review presenting conceptual applications of AI in cancer plasticity research; no empirical data, clinical outcomes, or comparative evidence reported.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Cellular plasticity characterized by changes in the fate and identity of cells, substantially fuels the process of tumorigenesis by enhancing growth, metastases and resistance to therapy under selective pressures.PubMed, Scopus, and Web of Science databases were comprehensively searched for the full papers published during 2013-2026 using the keywords such as artificial intelligence (AI), cellular plasticity, genomic, (epi)genomic, transcriptomic factors, oncological assessment and therapies.The present mini-review discusses the applications of AI-driven deep learning and machine learning models integrated with advanced next-generation sequencing and single-cell RNA analysis in elucidating the changes in the trajectories of plasticity in tumor ecosystem.It facilitates the deciphering of the molecular landscape associated with normal, metaplastic, and pre-malignant tissues in animal models and human clinical specimens.This would help in establishing new predictive signatures for risk stratification of tumors and predicting the response to drugs.AI plays an important role in drug development, boosts 3D structure of protein based drug discovery, analyzes the pharmacokinetic properties of drugs, and widens the scope of repurposed drugs.Recent trends foresee its application in providing tailored diagnosis, risk assessments, accelerating drug discovery and individualizing treatment regimens.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.